Direct and indirect costs of immunoglobulin replacement therapy in patients with common variable immunodeficiency (CVID) and X-Linked agammaglobulinemia (XLA) in Italy

Raffaella Viti; Andrea Marcellusi; Alessandro Capone; Andrea Matucci; Alessandra Vultaggio; Claudio Pignata; Giuseppe Spadaro; Angelo Vacca; Carolina Marasco; Carlo Agostini; Francesco Saverio Mennini

doi:10.1007/s40261-018-0688-3

Direct and indirect costs of immunoglobulin replacement therapy in patients with common variable immunodeficiency (CVID) and X-Linked agammaglobulinemia (XLA) in Italy

Raffaella Viti
, Andrea Marcellusi
, Alessandro Capone
, Andrea Matucci
, Alessandra Vultaggio
, Claudio Pignata
, Giuseppe Spadaro
, Angelo Vacca
, Carolina Marasco
, Carlo Agostini
, Francesco Saverio Mennini

Research output: Contribution to journal › Article › peer-review

1 Downloads (Pure)

Original language	English
Pages (from-to)	955-965
Journal	Clinical Drug Investigation
Volume	38
Issue number	10
Early online date	6 Sept 2018
DOIs	https://doi.org/10.1007/s40261-018-0688-3
Publication status	Published - 31 Oct 2018

Keywords

Allied health professions and studies

Access to Document

10.1007/s40261-018-0688-3

Marcellusi-A-42071-AAMAccepted author manuscript, 280 KBLicence: Unspecified

https://doi.org/10.1007/s40261-018-0688-3

Cite this

Viti, R., Marcellusi, A., Capone, A., Matucci, A., Vultaggio, A., Pignata, C., Spadaro, G., Vacca, A., Marasco, C., Agostini, C., & Mennini, F. S. (2018). Direct and indirect costs of immunoglobulin replacement therapy in patients with common variable immunodeficiency (CVID) and X-Linked agammaglobulinemia (XLA) in Italy. Clinical Drug Investigation, 38(10), 955-965. https://doi.org/10.1007/s40261-018-0688-3

@article{217807857b6d46cc9fe792c59bc01ac7,

title = "Direct and indirect costs of immunoglobulin replacement therapy in patients with common variable immunodeficiency (CVID) and X-Linked agammaglobulinemia (XLA) in Italy",

keywords = "Allied health professions and studies",

author = "Raffaella Viti and Andrea Marcellusi and Alessandro Capone and Andrea Matucci and Alessandra Vultaggio and Claudio Pignata and Giuseppe Spadaro and Angelo Vacca and Carolina Marasco and Carlo Agostini and Mennini, \{Francesco Saverio\}",

year = "2018",

month = oct,

day = "31",

doi = "10.1007/s40261-018-0688-3",

language = "English",

volume = "38",

pages = "955--965",

journal = "Clinical Drug Investigation",

issn = "1173-2563",

publisher = "Adis International Ltd",

number = "10",

}

Viti, R, Marcellusi, A, Capone, A, Matucci, A, Vultaggio, A, Pignata, C, Spadaro, G, Vacca, A, Marasco, C, Agostini, C & Mennini, FS 2018, 'Direct and indirect costs of immunoglobulin replacement therapy in patients with common variable immunodeficiency (CVID) and X-Linked agammaglobulinemia (XLA) in Italy', Clinical Drug Investigation, vol. 38, no. 10, pp. 955-965. https://doi.org/10.1007/s40261-018-0688-3

Direct and indirect costs of immunoglobulin replacement therapy in patients with common variable immunodeficiency (CVID) and X-Linked agammaglobulinemia (XLA) in Italy. / Viti, Raffaella; Marcellusi, Andrea; Capone, Alessandro et al.
In: Clinical Drug Investigation, Vol. 38, No. 10, 31.10.2018, p. 955-965.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Direct and indirect costs of immunoglobulin replacement therapy in patients with common variable immunodeficiency (CVID) and X-Linked agammaglobulinemia (XLA) in Italy

AU - Viti, Raffaella

AU - Marcellusi, Andrea

AU - Capone, Alessandro

AU - Matucci, Andrea

AU - Vultaggio, Alessandra

AU - Pignata, Claudio

AU - Spadaro, Giuseppe

AU - Vacca, Angelo

AU - Marasco, Carolina

AU - Agostini, Carlo

AU - Mennini, Francesco Saverio

PY - 2018/10/31

Y1 - 2018/10/31

KW - Allied health professions and studies

U2 - 10.1007/s40261-018-0688-3

DO - 10.1007/s40261-018-0688-3

M3 - Article

SN - 1173-2563

VL - 38

SP - 955

EP - 965

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

IS - 10

ER -